The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials

An efficacious COVID-19 vaccine is currently the world's leading research priority. Several nations have indicated they would be prepared to authorize...

COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now

Leaders must invest in evidence-based vaccine delivery strategies that generate demand, allocate and distribute vaccines, and verify coverage. There m...

COVID-19 - Important considerations for developing and using a vaccine

The novel coronavirus SARS-CoV-2 after emerging in China has caused a global pandemic. There are no clinical data yet suggesting that any available ca...

Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development

Women and children are widely considered the most vulnerable in times of emergency, whether in war or during a pandemic. The inclusion of pregnant and...

Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study

Researchers used an expanded SEIR model with social contact matrices to assess age-specific vaccine allocation strategies in India. Prioritizing COVID...

Efficacy and safety of COVID-19 vaccines in older people

Older people and care home residents are likely to be amongst the first to be vaccinated, but these patient groups are usually excluded from clinical...

COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines

The COVID-19 pandemic caused by SARS-CoV-2 has spread rapidly. Studies on the roles of asymptomatic and mildly infected subjects in disease transmissi...

Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

Radiologists should consider recent COVID-19 vaccination history as a possible differential diagnosis for patients with unilateral axillary adenopathy...